Canadian Hematology Society webinar

Immunoglobulin support for patients with hematologic malignancies: when should you discuss starting, how should you dose, and when is it safe to consider stopping

Quand
Où
Virtual

Event details

This webinar will provide an immunoglobulin update for secondary hypogammaglobulinemia patients and will cover evidence from clinical trials. This webinar is supported by a grant from Grifols and the Canadian Hematology Society Scientific Planning Committee has planned it to achieve scientific integrity, objectivity and balance. The target audience of this webinar are hematologists and trainees.

Presented by

Jeannie Callum
BA, MD, FRCPC – GROUP O NEGATIVE 
Director of Transfusion Medicine, Kingston Health Sciences Centre,
Professor, Department of Pathology and Molecular Medicine, Queen’s University

Abi Vijenthira, MD, SM, FRCPC
Hematologist, Princess Margaret Cancer Centre

Adil Adatia, MD, FRCPC
Assistant Professor, Department of Medicine, University of Alberta

Zoe McQuilten, MD
Professor, School of Public Health and Preventive Medicine, Monash University

Erica Wood, MD
Head, Transfusion Research Unit,
School of Public Health and Preventive Medicine, Monash University.
Haematologist, Monash Health, both in Melbourne, Australia

Guido Lancman, MD
Clinical Researcher and Assistant Professor
University Health Network, Princess Margaret Hospital and University of Toronto

Kathryn Webert, MD, FRCPC
Medical Director and Special Advisor, Canadian Blood Services

Learning objectives

  • Discuss the evidence from clinical trials for IVIG and SCIG for patients with hematologic malignancies and secondary hypogammaglobulinemia
  • Estimate the cost of 1 year of IVIG or SCIG for the healthcare system
  • Understand the evidence gap to be addressed by the RATIONAL-PT and IRIS trials

Registration

Registration is required using the Zoom registration form available on the Canadian Hematology Society website.

This activity is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Pathologists (CAP-AC). You may claim a maximum of 1.0 hours. Certificates of Attendance will be sent to all CHS members who participate.